Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2012, Article ID 671673, 11 pages
http://dx.doi.org/10.1155/2012/671673
Research Article

KU-32, a Novel Drug for Diabetic Neuropathy, Is Safe for Human Islets and Improves In Vitro Insulin Secretion and Viability

1Department of Pharmacology and Toxicology, University of Kansas, 5064 Malott Hall, Lawrence, KS 66045, USA
2Department of Physical Therapy and Rehabilitation Science, University of Kansas Medical Center, MS 2002, Kansas City, KS 66160, USA
3Department of Medicinal Chemistry, University of Kansas, Lawrence, KS 66045, USA

Received 3 August 2012; Revised 5 October 2012; Accepted 7 October 2012

Academic Editor: Mark A. Yorek

Copyright © 2012 Kevin Farmer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Kevin Farmer, S. Janette Williams, Lesya Novikova, et al., “KU-32, a Novel Drug for Diabetic Neuropathy, Is Safe for Human Islets and Improves In Vitro Insulin Secretion and Viability,” Experimental Diabetes Research, vol. 2012, Article ID 671673, 11 pages, 2012. https://doi.org/10.1155/2012/671673.